about
The Orosomucoid 1 protein is involved in the vitamin D - mediated macrophage de-activation processVirally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cellsGenomic expression during human myelopoiesisNovel definition files for human GeneChips based on GeneAnnot.TRAM (Transcriptome Mapper): database-driven creation and analysis of transcriptome maps from multiple sources.Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patternsHmgb3 is regulated by microRNA-206 during muscle regeneration.Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment.Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage.Motif discovery in promoters of genes co-localized and co-expressed during myeloid cells differentiation.Regeneration and repair in multiple sclerosis: the role of cell transplantation.Gene expression profiling in MDS and AML: potential and future avenues.Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: Focus on DNA repair genes.Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells.TFE3 transcription factor regulates the expression of MAFB during macrophage differentiation.Eosinophils, but not neutrophils, exhibit an efficient DNA repair machinery and high nucleolar activity.MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation.Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms.Tfe3 expression is closely associated to macrophage terminal differentiation of human hematopoietic myeloid precursors.TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts.Development of an IL-6 antagonist peptide that induces apoptosis in 7TD1 cells.miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis.c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression.Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib.Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation.Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.Embryonic stem-derived versus somatic neural stem cells: a comparative analysis of their developmental potential and molecular phenotype.Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1).Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice.Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulationThe extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migrationGene expression profiling of normal and malignant CD34-derived megakaryocytic cellsItalian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genesCorrelation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursorsHepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features
P50
Q24319095-4F84FBCA-3EC2-4E53-B41D-638CAE4DFE06Q28295388-063CBF4C-4272-4A40-90E7-CEC588AB55C8Q33293411-A09CD7D8-02A1-4E91-9FC6-B63EA0F89629Q33305718-3E5720F7-1077-4562-87E8-C0608AE0C582Q33824212-7DA60688-C45E-45CC-A292-5022CE96F9D5Q33939411-6EDAC85F-0DD3-4DF9-B2BB-A45DDA529663Q34389648-64637F75-349B-4E4E-9E8D-7F8EF1076E3FQ34545434-05EC8009-840E-4553-8075-D06EEBAC87C1Q34562206-3504D42D-4024-4E77-8AFB-E08F940B69B6Q37077442-6CEE4495-46E1-448D-A4CD-B36B059B4709Q37476152-24C1616A-F2FB-4A73-A2C9-E3E17283C3B3Q37858877-F5DD6C48-10AE-456F-BC5C-023179B590EBQ38309335-E6C21314-CFEE-4E96-A06A-CC2ADE702D9DQ38340941-CBD1401A-5921-444A-A45B-B60E975CC5F5Q38355460-4D7C1819-ECAC-48FC-B80F-5F0E118521B7Q38515620-C923CCD7-4A02-4686-A3D3-72255D0DA1E9Q39029590-C02D6FD9-3783-4FFB-93C3-DB1749687DADQ39482201-2A0B6730-6E76-48ED-88C0-EB46B8F8CFC7Q40219118-09D72DD3-483A-4B05-924C-BFB3A39A9E23Q40486854-06912A5C-ED98-4D48-B339-1B9679D16B6AQ40617651-81D51A4B-9208-4EAF-9473-5E48F4838176Q42082695-51C0853B-74A6-4658-906D-3EB3B15945C1Q42946150-431300BF-CE75-4D1E-8C0F-F20C3C9D5C6DQ43255365-01C92023-9185-4AB0-83A1-D07DCC2F2DDDQ44365700-3A3FB887-B31A-445C-B2C8-AD8D2FE2B767Q47274253-1BABE7DB-D806-4DFB-96C4-20196C64A957Q50951075-EF65EBAA-DEBC-40B7-AA28-6928C5803738Q51932956-A34EFD7B-D63F-42DE-BC47-21EB111A89DAQ54340834-9A2B90B7-0418-443D-8A94-33C63CA9E753Q56994200-EC76F537-B2D6-4924-A463-AEC1245FD533Q56996006-6C3F0A12-B8FA-4CF9-9C35-8592F103F75DQ57001073-74A791D7-0772-42A7-9ED0-F2343D598B39Q73209740-04AFA32E-B193-43D7-A1BD-CC74B534B745Q81833482-BFA3D5C1-8E1D-4EC3-BF2F-3991057F6D57Q82780679-4C5E849E-02CC-48D4-9B6E-8093CDA95A91
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sergio Ferrari
@ast
Sergio Ferrari
@en
Sergio Ferrari
@es
Sergio Ferrari
@nl
Sergio Ferrari
@sl
type
label
Sergio Ferrari
@ast
Sergio Ferrari
@en
Sergio Ferrari
@es
Sergio Ferrari
@nl
Sergio Ferrari
@sl
prefLabel
Sergio Ferrari
@ast
Sergio Ferrari
@en
Sergio Ferrari
@es
Sergio Ferrari
@nl
Sergio Ferrari
@sl
P106
P1153
7201817555
P21
P31
P496
0000-0002-4822-2521